These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14600526)

  • 1. How bad is HAART for the HEART?
    Reiss P
    AIDS; 2003 Nov; 17(17):2529-31. PubMed ID: 14600526
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coronary heart disease associated with the use of highly active antiretroviral therapy (HAART). A case report and review].
    Neumann T; Kondratieva J; Eggebrecht H; Wieneke H; Esser S; Bartel T; Erbel R
    Herz; 2005 Sep; 30(6):504-9. PubMed ID: 16170681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Highly active antiretroviral therapy. Building on experience in developing new strategies].
    Paukstadt W
    MMW Fortschr Med; 2011 May; 153(18):39. PubMed ID: 21604595
    [No Abstract]   [Full Text] [Related]  

  • 4. Intensive care of patients with HIV infection: HAART warming improvement but beware of future HAART (and heart) attacks.
    Morris A; Huang L
    Chest; 2004 May; 125(5):1602-4. PubMed ID: 15136363
    [No Abstract]   [Full Text] [Related]  

  • 5. [Also consider cardiovascular risk. Every HIV patient "his" HAART].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():58-60. PubMed ID: 19031565
    [No Abstract]   [Full Text] [Related]  

  • 6. HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy.
    Sterne JA; May M; Bucher HC; Ledergerber B; Furrer H; Cavassini M; Bernasconi E; Hirschel B; Egger M;
    J Intern Med; 2007 Mar; 261(3):255-67. PubMed ID: 17305648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ["HAART-attack" in young female HIV-patient].
    Pittl U; Keller DI; Kaiser CA; Battegay M; Pfisterer ME; Linka A
    Internist (Berl); 2006 Sep; 47(9):939-40, 942-3. PubMed ID: 16838185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of myocardial infarction in HIV-infected patients receiving HAART: a case report.
    Muise A; Arbess G
    Int J STD AIDS; 2001 Sep; 12(9):612-3. PubMed ID: 11516372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults.
    Lipshultz SE; Mas CM; Henkel JM; Franco VI; Fisher SD; Miller TL
    Expert Rev Anti Infect Ther; 2012 Jun; 10(6):661-74. PubMed ID: 22734956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond lipodystrophy: will toxicity issues ever outweigh the benefits of HAART?
    Vella S; Palmisano L
    J HIV Ther; 2003 May; 8(2):27-8. PubMed ID: 15587479
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial comment: Coronary artery disease and HIV infection--should we be concerned?
    Glesby MJ
    AIDS Read; 2001 May; 11(5):266. PubMed ID: 11592242
    [No Abstract]   [Full Text] [Related]  

  • 12. Left ventricular dysfunction in human immunodeficiency virus infection.
    Cade WT
    J Cardiometab Syndr; 2008; 3(2):83-7. PubMed ID: 18453807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical contractility impairment in HIV-infected patients: dependence on the class of antiretroviral drugs.
    Mercuro G; Cadeddu C; Nocco S; Deidda M; Mercuro S; Piano P; Ortu F; Manconi PE
    Int J Cardiol; 2013 Sep; 168(2):1538-9. PubMed ID: 23287696
    [No Abstract]   [Full Text] [Related]  

  • 14. [Scientific round table--highlights of the 16th CROI 2009. Focus on current therapy studies].
    Sankawa Y
    MMW Fortschr Med; 2009 Apr; 151(18):34-5. PubMed ID: 19769071
    [No Abstract]   [Full Text] [Related]  

  • 15. [HAART influences the lipids].
    Behrens G
    MMW Fortschr Med; 2009 Apr; 151(18):36-8. PubMed ID: 19769073
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum lipid levels associated with increased risk for cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1 infection.
    Koppel K; Bratt G; Eriksson M; Sandström E
    Int J STD AIDS; 2000 Jul; 11(7):451-5. PubMed ID: 10919487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocardial infarction in hiv patients treated with protease inhibitors: report of two cases].
    Sabbatani S; Dentale N
    Infez Med; 2002 Jun; 10(2):115-20. PubMed ID: 12702889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular risk factors associated with antiretroviral therapy].
    Pérez-Camacho I; Camacho A; Torre-Cisneros J; Rivero A
    Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():24-32. PubMed ID: 20172412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular complications associated with use of HIV protease inhibitors.
    Vittecoq D; Escaut L; Monsuez JJ
    Lancet; 1998 Jun; 351(9120):1959. PubMed ID: 9654286
    [No Abstract]   [Full Text] [Related]  

  • 20. Complications and side effects. Falling rates of heart attacks.
    TreatmentUpdate; 2009; 21(3):8-9. PubMed ID: 19623729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.